Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest

Elena Ashikhmina; Nicole Tomasello; Jean Marie Connors; Jama Jahanyar; Michael Davidson; K Annette Mizuguchi

doi:10.1016/j.athoracsur.2014.01.077

Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest

Ann Thorac Surg. 2014 Dec;98(6):2215-6. doi: 10.1016/j.athoracsur.2014.01.077. Epub 2014 Dec 1.

Authors

Elena Ashikhmina¹, Nicole Tomasello², Jean Marie Connors³, Jama Jahanyar², Michael Davidson², K Annette Mizuguchi⁴

Affiliations

¹ Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: eashikhmina@partners.org.
² Department of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
⁴ Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 25468095
DOI: 10.1016/j.athoracsur.2014.01.077

Abstract

We present a successful case of prevention of postoperative hemorrhage in a 70-year-old male on dabigatran, who developed an acute type A aortic dissection and subsequently underwent an emergent ascending aortic replacement.

Publication types

Case Reports

MeSH terms

Aged
Antithrombins / adverse effects
Antithrombins / therapeutic use
Aortic Aneurysm, Thoracic / surgery*
Aortic Dissection / surgery*
Benzimidazoles / adverse effects*
Benzimidazoles / therapeutic use
Dabigatran
Hemostatic Techniques
Humans
Male
Postoperative Hemorrhage / chemically induced*
Postoperative Hemorrhage / therapy
Vascular Surgical Procedures / methods*
beta-Alanine / adverse effects
beta-Alanine / analogs & derivatives*
beta-Alanine / therapeutic use

Substances

Antithrombins
Benzimidazoles
beta-Alanine
Dabigatran